The global brain implants market size is estimated to reach USD 11.20 billion by 2030, registering to grow at a CAGR of 9.9% from 2025 to 2030 according to a new report by Grand View Research, Inc. The rise in neurological disorders such as epilepsy, Parkinson’s disease, depression, and tremors as well as growing investments in R&D to develop cost-effective brain implants is attributing to the growth of the market.
The presence of a large population base suffering from various neurological and physiological disorders and conditions is expected to boost the demand for implants during the forecast period. For instance, as per the Parkinson’s Foundation 2016 report, over 10 million people globally are living with Parkinson’s disease (PD). Thus, the increasing cases of PD are expected to drive the market. However, the outbreak of the COVID-19 pandemic is restricting the growth of the market. For instance, as per the Neuromodulation Society of the U.K. and Ireland, in the U.K. all the NHS hospitals were instructed to suspend all the non-urgent elective surgeries due to the pandemic from 15th April in 2020 for at least three months.
In addition, technological advancements such as self-charging implants and memory chips are anticipated to provide the market with growth opportunities over the forecast period. For instance, in January 2020, Abbott’s Infinity DBS received an extended indication approval from the U.S. FDA for PD treatment.
Request a free sample copy or view report summary: Brain Implants Market Report
Deep brain stimulators (DBS) dominated the market and accounted for a share of 36.6% in 2024. DBS devices are experiencing heightened demand due to increasing prevalence of neurological disorders such as PD, epilepsy, and essential tremors.
Vagus nerve stimulators (VNS) are expected to grow at the fastest CAGR of 10.3% over the forecast period.
The chronic pain segment led the market and accounted for a share of 59.0% in 2024. Recent advancements in brain implant technology are driving increased adoption for chronic pain management.
North America brain implants market dominated the global market with a revenue share of 41.5% in 2024.
Grand View Research has segmented the global brain implants market based on product, application, and region:
Brain Implants Product Outlook (Revenue, USD Million, 2018 - 2030)
Deep Brain Stimulator
Spinal Cord Stimulator
Vagus Nerve Stimulator
Brain Implants Application Outlook (Revenue, USD Million, 2018 - 2030)
Chronic Pain
Epilepsy
Parkinson’s
Depression
Essential Tremor
Alzheimer’s
Brain Implants Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Mexico
Europe
UK
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
Japan
China
India
Australia
South Korea
Thailand
Latin America
Brazil
Argentina
Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait
List of Key Players of Brain Implants Market
Medtronic
Boston Scientific Corporation
Abbott
NeuroPace, Inc.
ALEVA NEUROTHERAPEUTICS
LivaNova PLC
SceneRay Co., Ltd.
"The quality of research they have done for us has been excellent..."